A unique strain of community-acquired Clostridium difficile in severe complicated infection and death of a young adult

被引:6
作者
Heslop, Orville D. [1 ]
Roye-Green, Karen [1 ]
Coard, Kathleen [2 ]
Mulvey, Michael R. [3 ]
机构
[1] Univ W Indies, Dept Microbiol, Kingston 7, Jamaica
[2] Univ W Indies, Dept Pathol, Kingston 7, Jamaica
[3] Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada
关键词
Clostridium difficile; Klebsiella pneumoniae; Community-Acquired Infection; Diarrhoea; Clindamycin; Pseudomembranous Colitis; Toxic Megacolon; EPIDEMIOLOGY; UPDATE;
D O I
10.1186/1471-2334-13-299
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Clostridium difficile is the major cause of nosocomial antibiotic-associated diarrhoea with the potential risk of progressing to severe clinical outcomes including death. It is not unusual for Clostridium difficile infection to progress to complications of toxic megacolon, bowel perforation and even Gram-negative sepsis following pathological changes in the intestinal mucosa. These complications are however less commonly seen in community-acquired Clostridium difficile infection than in hospital-acquired Clostridium difficile infection. To the best of our knowledge, this was the first case of community-acquired Clostridium difficile infection of its type seen in Jamaica. Case presentation: We report a case of a 22-year-old female university student who was admitted to the University Hospital of the West Indies, Jamaica with a presumptive diagnosis of pseudomembranous colitis PMC. She presented with a 5-day history of diarrhoea following clindamycin treatment for coverage of a tooth extraction due to a dental abscess. Her clinical condition deteriorated and progressed from diarrhoea to toxic megacolon, bowel perforation and Gram-negative sepsis. Clostridium difficile NAP12/ribotype 087 was isolated from her stool while blood cultures grew Klebsiella pneumoniae. Despite initial treatment intervention with empiric therapy of metronidazole and antibiotic clearance of Klebsiella pneumoniae from the blood, the patient died within 10 days of hospital admission. Conclusions: We believe that clindamycin used for coverage of a dental abscess was an independent risk factor that initiated the disruption of the bowel micro-flora, resulting in overgrowth of Clostridium difficile NAP12/ribotype 087. This uncommon strain, which is the same ribotype (087) as ATCC 43255, was apparently responsible for the increased severity of the infection and death following toxic megacolon, bowel perforation and pseudomembranous colitis involving the entire large bowel. K. pneumoniae sepsis, resolved by antibiotic therapy was secondary to Clostridium difficile infection. The case registers community-acquired Clostridium difficile infection as producing serious complications similar to hospital-acquired Clostridium difficile infection and should be treated with the requisite importance.
引用
收藏
页数:4
相关论文
共 12 条
[1]   Severe Clostridium difficile colitis:: The role of intracolonic vancomycin? [J].
Apisarnthanarak, A ;
Khoury, H ;
Reinus, WR ;
Crippin, JS ;
Mundy, LM .
AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) :328-329
[2]   An update on diagnosis, treatment, and prevention of Clostridium difficile -: Associated disease [J].
Aslam, Saima ;
Musher, Daniel M. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (02) :315-+
[3]   ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS DUE TO TOXIN-PRODUCING CLOSTRIDIA [J].
BARTLETT, JG ;
CHANG, TW ;
GURWITH, M ;
GORBACH, SL ;
ONDERDONK, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (10) :531-534
[4]   Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].
Cohen, Stuart H. ;
Gerding, Dale N. ;
Johnson, Stuart ;
Kelly, Ciaran P. ;
Loo, Vivian G. ;
McDonald, L. Clifford ;
Pepin, Jacques ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455
[5]   Outcomes in community-acquired Clostridium difficile infection [J].
Khanna, S. ;
Pardi, D. S. ;
Aronson, S. L. ;
Kammer, P. P. ;
Baddour, L. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (05) :613-618
[6]   The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study [J].
Khanna, Sahil ;
Pardi, Darrell S. ;
Aronson, Scott L. ;
Kammer, Patricia P. ;
Orenstein, Robert ;
St Sauver, Jennifer L. ;
Harmsen, W. Scott ;
Zinsmeister, Alan R. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (01) :89-95
[7]   The outcome of surgery in fulminant Clostridium difficile colitis [J].
Koss, K ;
Clark, MA ;
Sanders, DSA ;
Morton, D ;
Keighley, MRB ;
Goh, J .
COLORECTAL DISEASE, 2006, 8 (02) :149-154
[8]   Hypervirulent Clostridium difficile Strains in Hospitalized Patients, Canada [J].
Mulvey, Michael R. ;
Boyd, David A. ;
Gravel, Denise ;
Hutchinson, Jim ;
Kelly, Sharon ;
McGeer, Allison ;
Moore, Dorothy ;
Simor, Andrew ;
Suh, Kathryn N. ;
Taylor, Geoff ;
Weese, J. Scott ;
Miller, Mark .
EMERGING INFECTIOUS DISEASES, 2010, 16 (04) :678-681
[9]   Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A [J].
Murray, Ruth ;
Boyd, Dave ;
Levett, Paul N. ;
Mulvey, Michael R. ;
Alfa, Michelle J. .
BMC INFECTIOUS DISEASES, 2009, 9
[10]   Antimicrobial-associated risk factors for Clostridium difficile infection [J].
Owens, Robert C., Jr. ;
Donskey, Curtis J. ;
Gaynes, Robert P. ;
Loo, Vivian G. ;
Muto, Carlene A. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 :S19-S31